Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Harmful Algae. 2011 Jan 1;10(2):224–233. doi: 10.1016/j.hal.2010.08.006

Review of Florida Red Tide and Human Health Effects

Lora E Fleming 1,2, Barbara Kirkpatrick 3, Lorraine C Backer 4, Cathy J Walsh 3, Kate Nierenberg 3, John Clark 2, Andrew Reich 5, Julie Hollenbeck 1, Janet Benson 5, Yung Sung Cheng 5, Jerome Naar 6, Richard Pierce 3, Andrea J Bourdelais 6, William M Abraham 7,8, Gary Kirkpatrick 3, Julia Zaias 1, Adam Wanner 7, Eliana Mendes 7, Stuart Shalat 9, Porter Hoagland 10, Wendy Stephan 11, Judy Bean 12, Sharon Watkins 5, Tainya Clarke 2,8, Margaret Byrne 2, Daniel G Baden 6
PMCID: PMC3014608  NIHMSID: NIHMS232128  PMID: 21218152

Abstract

This paper reviews the literature describing research performed over the past decade on the known and possible exposures and human health effects associated with Florida red tides. These harmful algal blooms are caused by the dinoflagellate, Karenia brevis, and similar organisms, all of which produce a suite of natural toxins known as brevetoxins. Florida red tide research has benefited from a consistently funded, long term research program, that has allowed an interdisciplinary team of researchers to focus their attention on this specific environmental issue—one that is critically important to Gulf of Mexico and other coastal communities. This long-term interdisciplinary approach has allowed the team to engage the local community, identify measures to protect public health, take emerging technologies into the field, forge advances in natural products chemistry, and develop a valuable pharmaceutical product. The Review includes a brief discussion of the Florida red tide organisms and their toxins, and then focuses on the effects of these toxins on animals and humans, including how these effects predict what we might expect to see in exposed people.

Keywords: Florida red tide, red tide, neurotoxic shellfish poisoning, NSP, brevetoxins, harmful algal bloom, HAB, Karenia brevis, shellfish poisoning, respiratory irritation, marine toxin diseases, neurotoxic fish poisoning

1.0 Introduction

Florida red tides are predominantly associated with the blooms of the toxic dinoflagellate, Karenia brevis (K. brevis), formerly known as Gymnodinium breve and Ptychodiscus brevis. K. brevis produces a group of potent natural neurotoxins, the brevetoxins (i.e. PbTx or Ptychodiscus toxins), which can cause illness and mortalities in fish, seabirds, and marine mammals. Humans are susceptible to the effects of brevetoxin exposure, and public health surveillance activities have documented cases of intoxications from eating contaminated seafood and many respiratory complaints from inhaling contaminated aerosols (Kirkpatrick et al., 2004a).

Florida red tide blooms have been documented on the Florida west coast since the 1800s. More recently, Florida red tides have spread as far as the eastern coast of Mexico and have been entrained in the Gulf Loop, the current that brings Gulf waters to the shores of North Carolina. Other brevetoxin-producing dinoflagellate blooms have been identified in diverse geographic locations worldwide, including New Zealand, Australia and Scotland (Baden and Fleming 2007; Hernandez Becerril et al., 2007; Haywood et al., 2004; Kirkpatrick et al., 2004a; Nozawa et al., 2003; Steidinger et al., 1983).

In the 1980s and 1990s, there was increased interest in and research activity on harmful algal blooms (HABs). Much of this interest was driven by media attention on the discovery of several new HAB organisms purportedly associated with animal and human exposures and health impacts (e.g. Pseudo-nitzschia, Pfiesteria, and the phytoplankton producing the newly discovered toxins, the Azaspiracids) (Abraham and Baden 2006; Backer et al., 2003a; Backer et al., 2005a; Backer and Fleming 2008; Fleming et al., 2001; Fleming et al., 2004; Okamoto and Fleming 2005; Twiner et al., 2008; Zaias et al., 2010). There were also concerted efforts by the HAB research and response community to increase national and international attention on the apparent increase in HABs and the resulting increased risk for human exposure and subsequent adverse health effects (e.g. National HAB plan at http://www.esa.org/HARRNESS/). These activities lead to increased funding and interest in HAB research (e.g. the ecology and oceanography of harmful algal blooms [ECOHAB] http://www.whoi.edu/science/B/redtide/nationplan/ECOHAB/ECOHABhtml.html).

Over the past decade, there has been an intensive interdisciplinary and inter-agency research program focused on the possible exposures and health effects in humans and other animals from the Florida red tide toxins, particularly the aerosolized toxins (Abraham and Baden 2006; Backer et al., 2003a; Backer et al., 2005a; Fleming et al., 2004; Fleming et al., 2005a; Red tide research group 2002; Zaias et al., 2010). The findings of this particular research program are summarized below, with particular emphasis on the implications for human health.

2.0 Organisms

In the past decade, through the use of new technologies, it has become clear that K. brevis is only one of several different species of the Genus, Karenia, found throughout the world’s oceans. Blooms in the Gulf of Mexico may contain both K. brevis and K. mikimotoi (another brevetoxin-producing Karenia species) (Haywood et al., 2004). Other research has demonstrated varying brevetoxin production among the Karenia species, and even among individual K. brevis organisms. There have also been major advances in understanding the genomics of these dinoflagellates, such as the identification of the toxin-producing PKS genes, exploration of the impact of environmental change (e.g. temperature, light/dark cycles, etc) on gene expression, and the appreciation of the apparently unique complexity of the Karenia genome (Lidie et al., 2005; Monroe et al., 2008; Rein and Snyder 2006).

Despite what has been learned in the past few decades, there remains ongoing controversy concerning the sources and factors contributing to the bloom behavior of dinoflagellates, including K. brevis. The actual life cycle of K. brevis is still undefined, especially the location or existence of resting cysts. However, the major controversy has centered on the ability of anthropogenic change to influence K brevis bloom dynamics In particular, the relative importance of the role of nutrients (e.g. nitrates, phosphorus, silica, and iron) from coastal rivers, non-point coastal sources, or atmospheric deposition in initiating and/or sustaining K. brevis blooms is currently an important research and environmental policy topic (Brand and Compton 2007; Olascoaga et al., 2006; Walsh J et al., 2006).

3.0 Toxins

There has been an explosion of research on brevetoxins research over the past decade due to increased scientific and public health interest, and the potential to apply a range of new technologies. The brevetoxins (M.W. ~900) are lipid soluble, cyclic polyethers. In biological systems, they act to open voltage gated sodium (Na+) ion channels in cell membranes, leading to Na+ influx into the cell (Baden and Fleming 2007; LePage et al., 2003; Mattei et al., 2008; Twiner et al., 2007). There are over 10 different brevetoxins isolated in sea water blooms and K. brevis cultures in the laboratory, as well as multiple analogs and derivatives from the metabolism of shellfish and other organisms (Baden et al., 2005; Baden and Fleming 2007; Campbell et al., 2004; Michelliza et al., 2004 and 2007; Satake et al., 2008 and 2009). Recently, several laboratories have successfully synthesized brevetoxins de novo (Crimmins et al., 2009; Fuwa et al., 2006; Kuranaga et al., 2009). During Florida red tide blooms, the major brevetoxin produced is PbTx-2, along with lesser amounts of PbTx-1, PbTx-3, and other brevetoxin analogs (Cheng et al., 2004; Cheng et al., 2005a; Cheng et al., 2005b; Hardman et al., 2004; Lamberto et al., 2004; Pierce et al., 2003; 2005; 2008).

One of the most exciting discoveries of the last decade has been the identification of brevenal, a brevetoxin antagonist, in both K. brevis laboratory culture and in the environment during K. brevis blooms. This is apparently the first documented case of a toxin-producing organism also producing its own antagonist. Brevenal is produced by K. brevis in significant amounts, particularly during bloom senescence, and it acts at a different receptor site on nerve cells than the brevetoxins. Other brevetoxin analogs with varying degrees of antagonism or brevetoxin-like characteristics have also been identified (Abraham et al., 2003; Abraham et al., 2005a and 2005b; Bourdelais et al., 2002; Bourdelais et al., 2004a and 2004b; Bourdelais et al., 2005; Potera 2007).

From the point of view of human exposure and health, the brevetoxins are tasteless, odorless, and heat and acid stable. Thus, these toxins cannot be easily detected, nor can they be removed by food preparation procedures (Backer et al., 2003a; Backer et al., 2005a; Backer and Fleming 2008; Baden and Fleming 2007). Thus, the normal warning mechanisms (e.g. bad taste) or other protections (e.g. cooking contaminated seafood) are useless, and public health protection must focus on preventing human exposure (i.e. primary prevention).

Over the past decade, again thanks to the application of new technologies, major advances have been made in the detection of brevetoxins in a range of substrates, including seawater, air, seafood, and various animal and human clinical specimens (Dechraoui 2005; Dickey et al., 2004; Flewelling et al., 2005; Naar et al., 2007; Plakas et al., 2008; Poli et al., 2007; Weidner et al., 2004; Woofter et al 2003, 2005a and b, 2007). In particular, the creation, development and application of a new brevetoxin ELISA to all of these substrates, coupled with significant improvements in the detection limits of more traditional toxicologic analyses (e.g. Liquid Chromatography Mass Spectrometry (LCMS)), have allowed researchers and regulators to identify brevetoxins at very low levels in multiple environments and in a range of substrates (Naar et al., 2002 and 2004). This improved detection ability has been particularly important in advancing research to document exposures to brevetoxin-contaminated aerosols generated during Florida red tides and to identify the associated health effects in animals and humans. Specifically, using this highly sensitive ELISA, brevetoxins (particularly PbTx2 and 3, as well as brevenal) have been found in seawater and aerosols during active K. brevis blooms, as well as during non bloom periods (although at much lower levels).

In addition to establishing the concentrations of brevetoxins seen during a Florida red tide bloom (ranging from 15–90 mg/m3), the particle size of the brevetoxin aerosol has been characterized. The particles have a geometric mean of approximately 8–9 µ. This is important information in terms of the potential for respiratory effects of brevetoxin aerosols in humans. Particle size needs to be less than 5 µ to enter the lower airway; therefore, with a geometric mean of 8–9 µ, only 10–20% of these particles are small enough to enter the human lung (Cheng et al., 2004; Cheng et al., 2005a; Cheng et al., 2005b; Pierce et al., 2003; 2005; 2008). Using the same air sampling technologies, brevetoxin aerosols have been demonstrated to travel as much as a mile inland from coastal areas during an active Florida red tide, particularly when there are strong onshore winds (Kirkpatrick et al., 2010).

In addition to its application for aerosol analysis, improvements in brevetoxin detection and measurement have lead to the discovery of measurable levels of toxin in fish, both in the internal organs and in the filets that might be eaten by people. This creates the new possibility that there is an additional disease, “brevetoxin fish poisoning” (not just shellfish poisoning) that could effect marine mammals and people as discussed below (Flewelling et al., 2005; Kirkpatrick et al., 2009a; Naar et al., 2007).

4.0 Cellular processes

Cellular effects associated with both natural and experimental exposure to brevetoxins have been observed in the immune system of many species, although the mechanisms of action of brevetoxin exposure on immune cells and immune competence are not well understood. The number and variety of mediators, critical checkpoints, and key regulators in the immune system are vast, and brevetoxin may impact any one of these pathways individually or in combination. Full characterization of cellular consequences of brevetoxin exposure is critical to fully understand the impact of recurrent red tide events on human health.

Several potential mechanisms for brevetoxin immunotoxicity have been suggested, including the inhibition of cathepsin active sites (Katunuma et al., 2003; Sudarsanam et al., 1992); apoptosis (Bossart et al., 1998; Sayer et al., 2005; Walsh et al., 2008; Murrell and Gibson, 2009; 2010); the release of inflammatory mediators (Bossart et al., 1998; Murrell and Gibson 2010); effects on cell cycle (Han et al., 2003; Murrell and Gibson, 2009; Sayer et al., 2006; Walsh et al., 2005; 2008); and oxidative stress (Radwan and Ramsdell, 2006; Walsh et al., 2009). Brevetoxin exposure has been shown to have the potential to impair the immune system of many species, including manatee (Bossart et al., 1998; Walsh et al., 2005), cormorant (Kreuder et al., 2002), rat (Benson et al., 1999; 2004a and b; 2005) and loggerhead sea turtle (Walsh et al., 2010). Demonstrated effects resulting from brevetoxin exposure include: reduced phagocytosis (Benson et al., 1999); decreased plaque-forming ability (Benson et al., 1999; 2004a and b); and decreased lymphocyte proliferation (Walsh et al., 2005). Levels of lysozyme were found to be elevated in rescued loggerhead sea turtles (Walsh et al., 2010). In vitro experiments have demonstrated possible DNA damage (Murrell and Gibson, 2010; Sayer et al., 2005); chromosomal aberrations (Sayer et al., 2006); and effects on cellular growth (Han et al., 2003; Murrell and Gibson, 2009; Sayer et al., 2006; Walsh et al., 2008). Other immune system effects include mast cell degranulation (Hilderbrand et al., 2010) and histamine release (Abraham et al., 2005), cellular effects which may contribute to observed airway responses following the inhalation of aerosolized brevetoxins. Production of the pro-inflammatory cytokine, IL-6, was increased at both the protein (Hilderbrand et al., 2010) and gene (Murrell and Gibson, 2010) level in response to brevetoxin exposure. Several other cytokine genes with roles in pathogenesis of respiratory diseases were also shown to be increased in Jurkat E6-1 cells in response to in vitro brevetoxin exposure (Murrell and Gibson, 2010).

Apoptosis as potential mechanism of brevetoxin immunotoxicity was suggested based on the presence of interleukin-1 converting enzyme in lymphocytes and macrophages in manatee tissues collected during an epizootic (Bossart et al., 1998). DNA damage in human lymphocytes treated with brevetoxins in vitro (Sayer et al., 2005) supports apoptotic effects. Apoptosis, as measured by activity of caspase-3, was reported in a cell line (Jurkat E6-1) exposed to PbTx-2 and PbTx-6, but not when exposed to PbTx-3 (Walsh et al., 2008). Murrell and Gibson (2009) also demonstrated apoptosis occurring in brevetoxin-treated Jurkat cells through an increase in caspase 3/7 activity and activation of poly (ADP-ribose) polymerase (PARP), processes which were toxin-congener dependent, again with PbTx-3 failing to induce apoptosis. Several genes involved in apoptotic processes were affected by in vitro brevetoxin exposure in Jurkat cells (Murrell and Gibson, 2010).

Several studies have indicated that oxidative stress may play a role in the cellular response to brevetoxins. Glutathione depletion, an indication of oxidative stress, resulted in a U-937 human monocyte cell line treated with PbTx-2 (Walsh et al., 2009). Observations of DNA strand breaks (Sayer et al., 2005) and chromosomal aberrations (Sayer et al., 2006) are also consistent with oxidative stress. Brevetoxins have been shown to proceed through cytochrome P450 metabolic pathways, which may lead to oxidative damage. Evidence for cytochrome P450 involvement includes the metabolism of PbTx-2 by rat hepatocytes (Radwan and Ramsdell, 2006) and the U-937 human monocyte cell line (Walsh et al., 2009), and following treatment with cDNA-expressed rat cytochrome P450 enzymes (Radwan et al., 2005). The systemic administration of PbTx-2 to rats (Radwan et al., 2005) also demonstrated brevetoxin metabolism through cytochrome P450 pathways. Such metabolic processes can generate nucleophilic intermediates with the potential to bind DNA, and may have led to the brevetoxin-nucleic acid adducts detected in rat lung cells following both in vitro and in vivo exposure (Radwan and Ramsdell, 2008). Leighfield et al. (2009), however, reported that neither PbTx-2 nor the epoxide (PbTx-6) showed mutagenic potential. Some genes related to DNA damage, however, were increased in expression in Jurkat cells exposed to brevetoxin (PbTx-2) (Murrell and Gibson, 2010).

5.0 Animals

Significant die-offs of marine mammals, seabirds, and other animals throughout the 1990s and early 2000s enhanced awareness of the impacts of Florida red tides, and led to substantial increases in the resources available to support relevant interdisciplinary research (Kirkpatrick et al., 2004; Kreuder et al., 2002; Van Dolah et al., 2003; Zaias et al., 2010). In particular, the deaths of a significant population of the highly endangered Florida manatee during the prolonged 1996 Florida red tide focused attention on the potential health impacts for both animals and humans, particularly those associated with inhaling aerosolized toxins (Bossart et al., 2002; 2003a; 2003b). Another important finding demonstrating the impacts of brevetoxins on animals involved a major dolphin die-off in the early 2000s. Although not temporally associated with an active Florida red tide bloom, the cause of death was exposure to brevetoxins via the food web. Fish found in the dolphins’ stomachs tested positive for brevetoxins, particularly in the organs but also in the muscle. This episode raised the possibility of “brevetoxin fish poisoning” in humans and other animals who consumed whole fish contaminated with brevetoxins (Flewelling et al., 2005; Kirkpatrick et al., 2009a; Naar et al., 2007).

Recent laboratory studies in animals have been particularly important in exploring exposure and toxicity mechanisms, validating brevetoxin exposure, and demonstrating biological plausibility and possible mechanisms of action for the health effects reported in human studies (described below). Short and long term exposures of rodents (rats and mice) to aerosols containing brevetoxin have not demonstrated the same level of toxicity as seen in humans and other animal models. However, rodent studies have shown that aerosolized exposure to brevetoxins can lead to rapid systemic distribution, particularly to the neurologic system, implying potential adverse neurologic health impacts with respiratory exposure to aerosols (Benson et al., 2004a and 2004b; Benson et al., 2005a; Tibbetts et al., 2006). For example, exposing mice to aerosols containing brevetoxins (and exposing fish to water containing brevetoxins) caused changes in vestibular and auditory nerve function (Benson et al., 2005b; Lu and Tomchik 2002). Long term exposures of rodents to aerosolized brevetoxins have demonstrated immune dysfunction, including delay of viral clearance and possible enhancement of the pathogenicity of influenza A (J Benson, Lovelace Respiratory Research Institute, personal communication). Rodent studies have also been important in demonstrating that brevetoxins delivered in aerosols are not teratogenic in multi-generational exposure studies (Benson et al., 2006).

The sheep model of asthma has served as an important tool for the exploration of possible health effects from aerosolized brevetoxin exposures. The highlight of this model is that the sheep respond to brevetoxin exposures at levels similar to those experienced by humans at the beach during a Florida red tide bloom (Abraham and Baden 2006; Abraham et al., 2003; Abraham et al., 2004; Abraham et al., 2005a and b; Abraham et al., 2009; Zaias et al., in press). This model has demonstrated that both asthmatic and non asthmatic sheep react with significantly decreased respiratory function and experience dose-dependent airway hypersensitivity after exposure to very small concentrations of aerosolized brevetoxins (~10 pg/ml of PbTx-2 or PbTx-3, the two main toxins found in the air during a K. brevis bloom). In the asthmatic sheep, these effects are larger and last longer, particularly when there has been exacerbation of the asthma prior to the brevetoxin exposure. Chronic exposures in sheep demonstrate reduced function of alveolar macrophages, suggesting immune dysfunction (Zaias et al in press). This same model system has been important in the exploration of the pathogenesis and binding of many different types of brevetoxins and their analogs, including the new antagonist brevenal, since it allows for precise exposure delivery and effect measurement.

6.0 Humans

Humans can be exposed to brevetoxins through food, water, and air (Backer et al., 2003a; Backer et al., 2005a; Backer and Fleming 2008; Fleming et al., 2001; Fleming et al., 2002; Okamoto and Fleming 2005). Until recently, the health effects associated with exposure to Florida red tide have been driven primarily by anecdote and case report, as well as the evidence described above from wild marine mammal illnesses and deaths. It is only in the past decade that interdisciplinary epidemiologic research has been applied to the exposures and health effects of Florida red tide and its toxins.

6.1. Consumption of contaminated seafood

The traditional illness associated with exposure to Florida red tide and its toxins through the consumption of contaminated shellfish is neurotoxic shellfish poisoning (NSP). The assumption has been that this is a relatively rare disease due to the stringent monitoring and timely closure of toxin-contaminated shellfish beds in the Gulf of Mexico. However, a recent comprehensive Review by Watkins et al., (2009) found that, this illness is likely to be misdiagnosed, and is probably more common than previously thought, particularly among visitors and subpopulations not informed of shellfish bed closures or shellfish harvesting bans. Based on a review of emergency room cases in Florida, it is clear that NSP can be a severe acute disease with emergency room and intensive care required during the first hours, and, in severe cases days, to prevent respiratory failure (Abraham A et al., 2008; Watkins et al., 2009). Even with a severe acute illness, victims are usually discharged from the hospital within days; there is almost nothing known about the subchronic or chronic sequelae of an acute NSP episode. Furthermore, nothing is known about the possible health effects of long term very low level exposures from eating shellfish with low levels of contamination over a long period of time.

With regards to the possible new illness of “brevetoxin fish poisoning,” it is not known if there are human cases of illness associated with eating brevetoxin-contaminated finfish. Nevertheless, evaluation of emergency room admissions for gastrointestinal illnesses during an active Florida red tide and again when there was not an active bloom demonstrated significantly increased gastrointestinal illness emergency room admissions during the active Florida red tide period (Flewelling et al., 2005; Kirkpatrick et al., 2009a; Naar et al., 2007; Perez Linares et al., 2009).

6.2 Inhalation exposure

The major advances in the past decade in defining the nature and extent of human health effects from exposure to Florida red tide and its toxins have been in the area of aerosol exposures (Backer et al., 2003b; Backer et al., 2005b; CDC 2008; Fleming et al., 2005a and b; Fleming et al., 2009; Kirkpatrick et al., 2002; Kirkpatrick et al., 2004a; Kirkpatrick et al., 2006; Kirkpatrick et al., 2009a; Kirkpatrick et al., 2009b; Kirkpatrick et al., 2010; Milian et al., 2007; Quirino et al., 2004; Steensma 2007). An early study demonstrated that (similar to the studies in the sheep model) all persons, regardless of their underlying respiratory function, can be affected by exposure to aerosols generated during Florida red tides. Complaints included respiratory symptoms which appeared to move from the upper to the lower respiratory track with increasing exposure levels of the aerosolized brevetoxins (Backer et al., 2003b). Subsequent studies in a group of very healthy non-asthmatic lifeguards found significantly increased self-reports of respiratory symptoms after completing an 8 hour work shift during an active Florida red tide confirmed by finding brevetoxin in the water and in aerosols. There was no increase in symptoms after completing a work shift in the absence of a Florida red tide. Measurements in these lifeguards did not demonstrate a significant decrease in their pulmonary function associated with exposure to aerosolized brevetoxins during an active Florida red tide nor during a non exposure period (Backer et al., 2005b).

While the results in the lifeguards suggested that the effects from aerosolized Florida red tide were acute and of minor significance in a very healthy cohort, there are other groups of people for whom these aerosols might pose an important health risk. Asthmatics aged 12 and older had significant increases in self-reported respiratory symptoms and significant decreases in respiratory function measured by spirometry after only 1 hour of acute exposure to aerosolized brevetoxins during an active Florida red tide. The changes in symptoms and lung function were not present when the participants went to the beach when there was no active Florida red tide (Cheng et al., 2004; Cheng et al., 2005a; Cheng et al., 2005b; Fleming et al., 2005a; Fleming et al., 2007b; Milian et al., 2007; Pierce et al., 2003; 2005; 2008;). In addition, there was a dose response relationship to the symptoms (but not the pulmonary function changes) during the 1 hour of brevetoxin exposure (Fleming 2009). The subgroups that appeared to react most significantly in terms of both symptoms and pulmonary function changes to the 1 hour brevetoxin exposure were those reporting recent use of asthma medications (suggestive of less controlled asthma), and those who lived over 1 mile inland from the coastal regions (possibly relatively unexposed prior to the study beach exposure) (Fleming et al., 2005b; Fleming et al., 2007b; Fleming et al., 2009; Kirkpatrick et al., 2010; Milian et al., 2007).

As seen in the sheep asthma model, when the asthmatic study participants were followed up over a 5 day time period, their symptoms persisted for 3–4 days after the acute 1 hour beach exposure (Kirkpatrick et al., 2009b). Even more importantly, their pulmonary function decreased even further the day after the 1 hour beach exposure and did not recover for the subsequent 4 more days of follow up. Again, the less controlled asthmatics and those who live inland seemed to experience the greatest changes in symptoms and lung function.

Another way to assess the public health impact from an environmental exposure is to examine contacts with the local health care systems. Kirkpatrick et al. (2006) evaluated emergency room admissions during an active Florida red tide period and compared them with admissions during a non active period. The authors found an increase in emergency room admissions for acute and subchronic respiratory health effects (e.g. asthma, bronchitis, and pneumonia) during active Florida red tides, particularly for coastal residents. Another study compared calls to the Poison Information Center with and without reported Florida red tide exposure. The results suggested that callers experienced prolonged respiratory symptoms, and increased use of medication and doctor visits, among those who were exposed to the Florida red tide aerosols (Quirino et al., 2004).

Taken together, these data suggest that at least in asthmatics (and possibly in others with underlying respiratory illness), exposure to aerosolized Florida red tide toxins leads to acute, subacute, and possibly more chronic illness (Kirkpatrick et al., 2006; Kirkpatrick et al., 2009b; Zaias et al., 2010). However, initial evaluation of longitudinal data in the cohort of asthmatic residents who were exposed almost annually to K. brevis blooms did not identify any particular subgroup of asthmatics at increased risk, nor does there appear to be any longitudinal health effect over years of intermittent exposure. Despite potential intermittent brevetoxin environmental exposures, continued intermittent exposure to aerosolized Florida red tide toxins over several years follow up did not appear to cause major respiratory changes in the asthmatic study group,; however, these results need to be explored further to be confirmed (J. Bean, the CincinnatiChildrens Hospital, personal communication ).

7.0 Treatment and Prevention

The sheep model of asthma discussed above has demonstrated that commonly used asthma medications (e.g. beta agonists, cromolyn, and steroids), as well as antihistamines and brevenal, can prevent the respiratory effects of subsequent aerosolized brevetoxin exposure. In addition, the beta agonists and brevenal can reverse or treat these effects if given after the brevetoxin exposure (Abraham and Baden 2006; Abraham et al., 2003; Abraham et al., 2004; Abraham et al., 2005a and b; Abraham et al., 2009; Zaias et al., in press). The sheep model is now being used to explore the mechanisms of the cellular response to brevetoxin exposure in the lung, including the possibility that there are additional brevetoxin receptors in addition to those associated with sodium channels. Finally, aside from the effects of Florida red tide aerosols, experiments with brevenal in the sheep model have identified a potentially powerful new pharmacokinetic activity. Specifically, administration of brevenal substantially increased the mucociliary clearance in the lung. Furthermore, the similarities between the response to brevenal and sodium channel blockers in mucus clearance, suggest that brevenal might be a possible candidate to treat other diseases with impaired mucus clearance (such as chronic obstructive lung disease (COPD) or cystic fibrosis) (Clarke et al., 2008; Sabeter et al., 2008; Sabeter et al., 2009; Potera 2007; Raloff 2005).

While there is still much more to learn, we can develop some preliminary public health messages about exposure to Florida red tides. For example, during an active Florida red tide, particularly if the bloom is close to the coast and with a strong onshore wind, asthmatics and others with underlying respiratory diseases should consider staying inland (at least 1–2 miles from the coast) or indoors with the windows shut and air conditioning on (Fleming et al., 2005a; Kirkpatrick et al., 2010). Other research research by Cheng et al., (Y-S Cheng, Lovelace Respiratory Research Institute, personal communication) has demonstrated that inhalation of brevetoxiin-contaminated particles from Florida red tide aerosols can be decreased by up to 45% by using a paper surgical mask. However, it is not known for how long this protective effect lasts, nor is it known if this is a sufficient decrease in exposure to the aerosolized brevetoxins to protect asthmatics and other susceptible persons with compromised lung function.

8.0 Economics

There has been considerable interest in quantifying the economic impacts of HABs in general in the US since the work of Hoagland and Anderson which estimated these impacts based on public health, commercial fisheries, recreation and tourism, and monitoring and management effects (Anderson et al., 2000; Hoagland et al, 2002). Since then, as part of a cost-of-illness study, Hoagland et al., (2009) created a model to explore the relationship between K. brevis blooms and respiratory illness visits to hospital emergency rooms while controlling for environmental factors, disease, and other factors. The model included data on emergency room visits for respiratory complaints, K. brevis cell densities, and measures of pollen, pollutants, community illness (influenza), and intra-annual population changes. K. brevis cell counts lagged by 1 week from measurement (as well as low air temperatures, influenza outbreaks, high pollen counts, and tourist visits) were predictive of the number of respiratory-specific emergency room diagnoses. The authors estimated that capitalized estimated marginal costs-of-illness for emergency room respiratory illnesses associated with K. brevis blooms in Sarasota County (FL) ranged from $0.5 to $4 million, depending upon bloom severity. Of note, this study did not capture the entire cost of interacting with other components of the medical care system (such as visits to the pharmacy, primary care physicians or specialists, or hospitalizations).

Nierenberg et al., (2010) evaluated lifeguard attendance data during an active Florida red tide bloom. Absenteeism results in significant direct and indirect increased costs to organizations; absenteeism associated with the lifeguards and Florida red tide was significantly increased during an active bloom with costs estimated of $3,000/bloom. The capitalized costs of lifeguard absenteeism were estimated to be up to $100,000 at Sarasota County (Florida) beaches alone. The costs could not be estimated for presenteeism, that is, the cost of people coming to work when they are ill. However, lifeguards reported not only that they experienced adverse health effects from exposure to Florida red tide, but also that they believed their attentiveness and abilities to take preventative actions decreased when they worked during a bloom. The authors noted that this presenteeism could affect beach safety by hampering the abilities of lifeguards to identify and respond to emergency situations.

9.0 Monitoring, surveillance, outreach & education

Over the decade, there has been an explosion of outreach and education on Florida red tide, using diverse mechanisms and targeted at a range of populations. Kuhar et al., (2009) investigated the public perception and consequent reactions to Florida red tides among persons living and visiting coastal areas regularly affected by the HABs. Using questionnaire surveys and semi-structured interviews, the researchers explored various perceptions of the risk surrounding red tides along two beaches on the west coast of Florida. Among other findings, the results indicated that coastal residents and tourists may not have efficiently delivered and up-to-date information about Florida red tides and their impacts because of inconsistent public outreach. Nierenberg et al., (in press) further pursued these issues assessing the public knowledge about Florida red tide. Again gaps in public knowledge regarding Florida red tides were identified, even among coastal residents; and preferred information sources for obtaining information on Florida red tide were also identified. Specifically, the biology of Florida red tide blooms, what is and is not safe to ingest (commercial versus recreationally caught), swimming in, and Florida red tide associated human mortalities were found to be inconsistently and incorrectly responded to by both tourists and residents of coastal Florida counties. The informational sources preferred by 80% of tourists and by 53% of residents was the Internet; these participants also looked to Mote Marine Laboratory, the local science organization, the majority of the time (66%), while toll free numbers were rarely (14%) used by tourists.

The Beach Conditions Reporting System (http://coolgate.mote.org/beachconditions/; tel: 1–941-BEACHES) has been set up to collect and report real time data from life guards and beach managers on a range of beach-related issues (including respiratory irritation and dead fish) to the public. The information is accessible through phone or internet. Initiated in Sarasota County (FL), the Beach Conditions Reporting System has now spread throughout the western coast of Florida, with plans to extend this reporting system throughout the Gulf of Mexico (Kirkpatrick et al., 2004b; Kirkpatrick et al., 2008; Nierenberg et al., 2009). The Florida Poison Information Center has created and formally evaluated a 24/7 toll free number (tel: 888 232 8635) on aquatic toxins which allows the caller to access information on a range of aquatic toxin issues including Florida red tide in English and Spanish, as well as speak directly with a trained Florida Poison Information Specialist (Fleming et al., 2007b).

Monitoring information for the Florida red tide organism has become more available through the Florida Fish and Wildlife Commission (http://research.myfwc.com/features/view_article.asp?id=9670), and through the NOAA Gulf of Mexico HAB Bulletin (http://tidesandcurrents.noaa.gov/hab/bulletins.html). The FWC monitoring data are collected by a volunteer network, and report K. brevis cell counts throughout Florida marine waters biweekly. The NOAA HAB Bulletin uses these monitoring data, the Beach Conditions Reporting Data, and satellite remote sensing data incorporated into a wind and current model to identify and predict the location of Florida red tide blooms throughout the Florida coast. Of note, ongoing work by other researchers is also leading to increasingly accurate detection and predictions of Florida red tide blooms. These efforts include creating and making operational an optical phytoplankton discriminator (OPD) also known as the “BreveBuster.” The BreveBuster has been installed on a variety of different platforms including fixed buoys and in the payload of autonomous underwater vehicles (AUVs). The Slocum glider (Web Research, Falmouth, MA) AUVs are buoyancy-driven through the water column, and use the OPD to identify blooms. The AUVs surface periodically to send back real-time data via satellite). Other efforts include detecting of K. brevis by off-shore portable buoys (again with transmission of real time data by satellite), and improvements in the algorithms used to detect K. brevis blooms using remote sensing data (Carvahlo et al., 2010; G Kirkpatrick et al., 2000; Stumpf et al., 2009; Wynne et al., 2005; J Walsh 2006).

The Centers for Disease Control and Prevention (CDC), in collaboration with a range of State Departments of Public Health, has created a unique surveillance system that captures health effects and exposure information for humans and animals, as well as information characterizing the blooms themselves; the system is called the Harmful Algal Bloom-related Illness Surveillance System (HABISS) (http://www.cdc.gov/hab/surveillance.htm). This system incorporates data from the National Poison Data System, public health reports, and media reports, as well as environmental monitoring data. Major objectives of this system are to establish baselines for the incidence of the harmful algal bloom-related illnesses (including for Florida red tide), and to identify new occurrences of HABs that cause human and animal exposures and health effects.

Finally, community groups (e.g. Solutions to Avoid Red Tide [START] http://www.start1.com/), health educators, public health managers, and researchers have developed targeted materials to educate various groups about exposure to and health effects from Florida red tide toxins, including: coastal residents and tourists, healthcare providers, and beach managers. The Florida Department of Health has established a fulltime position called the Aquatic Toxins Coordinator. In addition to coordinating surveillance and outreach about HABs, including Florida red tide, the Coordinator has established a model HAB response plan that can be adapted and adopted for all of the Florida County Departments of Health (http://www.myfloridaeh.com/medicine/aquatic/index.html). The Florida Department of Health in conjunction with START, Mote Marine Laboratory, the University of Miami Oceans and Human Health Center, and the Florida Poison Information Center have also created a range of educational materials including: annotated Power Points® presentations and video for healthcare providers and beach managers, (http://www.med.miami.edu/poisoncontrol/x57.xml and http://www.mote.org/niehsredtidestudy/) for tourists and residents. In addition, they have created the START Florida Red Tide Card and traveling Florida Red Tide Exhibit, and Florida red tide beach signage (Figure 1).

Figure 1.

Figure 1

Florida Red Tide Beach Signage (Florida Dept of Health, START, Mote Marine, University of Miami Oceans & Human Health Center, Florida Poison Information Center, and Ms Wendy Stephan MPH)

10.0 Conclusions

This Review of recent developments in Florida red tide research has focused on the potential exposures and subsequent health effects in humans and animals. It has necessarily left out additional exciting basic science and ecology research which is also important and relevant. Nevertheless, the lessons to be learned from this Review include not only the establishment of new and potential exposures and health effects from Florida red tides and their toxins, but also a clear message that the application of new technologies, additional resources, and the focus of truly interdisciplinary research efforts can lead to remarkable new discoveries and insights in harmful algal bloom research, as well as expanded resources for effected communities in knowledge, outreach and education. Without these interdisciplinary efforts and resources, brevenal would not have been discovered, and a new and important natural product which could treat chronic obstructive pulmonary disease (COPD) and cystic fibrosis, deadly human illnesses, would never have been developed (Fleming et al., 2005a). Furthermore, the issue of actue and subacute respiratory effects after exposure to aerosolized Florida red tide toxin exposure was considered to be anecdotal until formal interdisciplinary epidemiologic research in collaboration with effected coastal residents demonstrated measurable respiratory effects, particularly among asthmatics (Fleming et al., 2007a). One can only imagine the new and important discoveries that can be made by the HAB research community with the application of resources and interdisciplinary research activities in the future.

Acknowledgement

This study was funded in part by the National Institute for Environmental Health Sciences (NIEHS) P01 ES10594; the Centers for Disease Control and Prevention (CDC); the Florida Department of Health; the National Science Foundation (NSF)-NIEHS Oceans and Human Health Center at the University of Miami Rosenstiel School of Marine and Atmospheric Sciences (NSF OCE0432368/OCE0911373; NIEHS P50 ES12736).

Abbreviations

PbTx

Brevetoxin

cm

Centimeter

COPD

chronic obstructive pulmonary disease

ELISA

Enzyme linked immunosorbent assay

HAB

Harmful algal bloom

HABISS

Harmful Algal Bloom-related Illness Surveillance System

K. brevis

Karenia brevis

km

Kilometer

LCMS

Liquid chromatography mass spectroscopy

mg/m3

milligram per meter cubed

ug/L

Microgram per liter

ng/m3

nanogram per meter cubed

NSP

Nurotoxic shellfish poisoning

OPD

Optical phytoplankton discriminator

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Abraham A, Plakas SM, Flewelling LJ, El Said KR, Jester EL, Granade HR, White KD, Dickey RW. Biomarkers of neurotoxic shellfish poisoning. Toxicon. 2008;52(2):237–245. doi: 10.1016/j.toxicon.2008.04.175. [DOI] [PubMed] [Google Scholar]
  2. Abraham WM, Bourdelais AJ, Sabater JR, Ahmed A, Lee A, Serebriakov I, Baden DG. Airway responses to aerosolized brevetoxins in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. 2005b;171(1):26–34. doi: 10.1164/rccm.200406-735OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abraham WM, Ahmed A, Bourdelais A, Baden DG. Effects of novel antagonists of polyether brevetoxin (PbTx)-induced bronchoconstriction in allergic sheep. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. Harmful Algae. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 496–498. [Google Scholar]
  4. Abraham WM, Baden DG. Aerosolized Florida red toxins and human health effects. Oceanography. 2006;19(2):107–109. doi: 10.5670/oceanog.2006.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Abraham WM, Ahmed A, Bourdelais AJ, Baden DG. Pathophysiologic Airway Responses to Inhaled Red Tide Brevetoxin in Allergic Sheep. The Toxicologist. 2003;72(S-1):115. [Google Scholar]
  6. Abraham WM, Bourdelais AJ, Ahmed A, Serebriakov I, Baden DG. Effects of inhaled brevetoxins in allergic airways: Toxin - allergen interactions and pharmacologic intervention. Environ Health Perspect. 2005a;113(5):632–637. doi: 10.1289/ehp.7498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Abraham WM, Zaias J, Bourdelais AJ, Baden DG. Prolonged Airway Hyperresponsiveness After SubChronic Inhalation Exposure to Brevetoxins. Society of Toxicology. 2000:286. (Abstract) [Google Scholar]
  8. Anderson DM, Hoagland P, Kaoru Y, White AW. Estimated annual economic impacts from harmful algal blooms (HABs) in the United States. Massachusetts: Department of Biology, Woods Hole Oceanographic Institution, Woods Hole; WHOI-2000-11. 2000 http://www.redtide.whoi.edu/hab/pertinentinfo/EconomicspReport.pdf.
  9. Backer L, Fleming LE, Rowan A, Baden D. Hallegraeff GM, Anderson DM, Cembella AD, editors. Epidemiology and Public Health of Human Illnesses Associated with Harmful Marine Phytoplankton. Geneva, Switzerland: UNESCO/WHO; UNESCO Manual on Harmful Marine Algae. 2003a:725–750.
  10. Backer LC, Fleming LE. Epidemiologic Tools to Investigate Oceans and Public Health. In: Walsh PJ, Smith SL, Fleming LE, Solo-Gabriele H, Gerwick WH, editors. Oceans and Human Health: Risks and Remedies from the Sea. New York: Elsevier Science Publishers; 2008. pp. 201–218. [Google Scholar]
  11. Backer LC, Schurz Rogers H, Fleming LE, Kirkpatrick B, Benson J. Phycotoxins in Marine Seafood. In: Dabrowski W, editor. In Chemical and Functional Properties of Food Components: Toxins in Food. Boca Raton, FL: CRC Press; 2005a. pp. 155–190. [Google Scholar]
  12. Backer LC, Fleming LE, Rowan A, Cheng YS, Benson J, Pierce RH, Zaias J, Bean J, Bossart GD, Johnson D. Recreational Exposure to Aerosolized Brevetoxins During Florida Red Tide Events. Harmful Algae. 2003b;2:19–28. [Google Scholar]
  13. Backer LC, Kirkpatrick B, Fleming LE, Cheng YS, Pierce R, Bean JA, Clark R, Johnson D, Wanner A, Tamer R, Zhou Y, Baden DG. Occupational exposure to aerosolized brevetoxins during Florida red tide events: Effects on a healthy worker population. Environ Health Perspect. 2005b;113(5):644–649. doi: 10.1289/ehp.7502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Baden D, Fleming LE. Brevetoxins. Geneva, Switzerland: Food and Agriculture Organization/World Health Organization. World Health Organization; Biotoxins in Bivalve Molluscs. 2007 ( ftp://ftp.fao.org/es/esn/food/biotoxin_report_en.pdf)
  15. Baden DG, Bourdelais AJ, Jacocks H, Michelliza S, Naar J. Natural and derivative brevetoxins: Historical background, multiplicity, and effects. Environ Health Perspect. 2005;113(5):621–625. doi: 10.1289/ehp.7499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Benson J, Hahn FF, Tibbetts BM, Bowen LE, March TF, Langley R, Murray TF, Bourdelais AJ, Naar J, Zaias J, Baden DG. Steidinger KA, Landsberg JH, Tomas CR, Vargo GA. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004a. Florida red tide: inhalation toxicity of Karenia brevis extract in rats; pp. 502–504. [PMC free article] [PubMed] [Google Scholar]
  17. Benson JM, Stagner BB, Martin GK, Friedman M, Durr SE, Gomez A, McDonald J, Fleming LE, Backer LC, Bourdelais A, Naar J, Baden DG, Lonsbury-Martin BL. Cochlear function in CBA/CaJ mice following inhalation of brevetoxin-3. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2005b;191(7):619–626. doi: 10.1007/s00359-005-0613-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Benson JM, Hahn FF, March TH, McDonald JD, Gomez AP, Sopori MJ, Bourdelais AJ, Naar J, Zaias J, Bossart GD, Baden DG. Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days. Environ Health Perspect. 2005a;113:626–631. doi: 10.1289/ehp.7497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Benson JM, Tischler DL, Baden DG. Uptake and tissue distribution and excretion of brevetoxin 3 administered to rats by intratracheal instillation. J Toxicol Environ Health. 1999;56:345–355. doi: 10.1080/009841099157656. [DOI] [PubMed] [Google Scholar]
  20. Benson J, Hahn F, March T, McDonald J, Sopori M, Seagrave J, Gomez A, Bourdelais A, Naar J, Zaias J, Bossart G, Baden D. Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days. J Toxicol Environ Health A. 2004;67(18):1443–1456. doi: 10.1080/15287390490483809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Benson JM, Hahn FF, March TH, McDonald JD, Gomez AP, Sopori MJ, Bourdelais AJ, Naar J, Zaias J, Bossart GD, Baden DG. Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days. Environ Health Perspect. 2005b;113(5):626–631. doi: 10.1289/ehp.7497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Benson J, Hahn F, March T, McDonald J, Sopori M, Seagrave J-C, Gomez A, Bourdelais A, Naar J, Zaias J, Bossart G, Baden D. Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days. J Toxico Environ Health, Part A. 2004b;67(18):1443–1456. doi: 10.1080/15287390490483809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Benson JM, Gomez AP, Staton GL, Tibbbetts BM, Fleming LE, Backer LC, Reich A, Baden DG. Placental transport of brevetoxin-3 in CD-1 mice. Toxicon. 2006;48:1018–1026. doi: 10.1016/j.toxicon.2006.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Bossart GD, Baden DG, Ewing R, Roberts B, Wright S. Brevetoxicosis in manatees (Trichechus manatus latirostris) from the 1996 epizootic: gross, histopathologic, and immunocytochemical features. Toxicol Pathol. 1998;26(2):276–282. doi: 10.1177/019262339802600214. [DOI] [PubMed] [Google Scholar]
  25. Bossart GD, Baden DG, Ewing RY, Wright SD. Manatees and brevetoxicosis. In: Pfeiffer C, editor. Molecular and Cell Biology of Marine Mammals. Melbourne, FL: Krieger Publishing Co; 2002. pp. 205–212. [Google Scholar]
  26. Bossart GD, Meisner R, Rommel SA, Ghim S, Jenson AB. Pathological features of the Florida manatee cold stress syndrome. Aquatic Mammals. 2003a;29(1):9–17. [Google Scholar]
  27. Bossart GD, Meisner R, Varela R, Mazzoil M, McCulloch S, Kilpatrick D, Friday R, Murdoch E, Mase B, Defran RH. Pathologic findings in stranded Atlantic bottlenose dolphins (Tursiops truncatus) from the Indian River Lagoon, Florida. Florida Scientist. 2003b;66(3):226–238. [Google Scholar]
  28. Bourdelais A, Campbell S, Kubanek J, Wright J, Baden DG. Florida’s red tide dinoflagellate Karenia brevis may modulate its potency by producing a non-toxic competitive antagonist. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004a. pp. 113–115. [Google Scholar]
  29. Bourdelais AJ, Campbell S, Jacocks H, Naar J, Wright JLC, Carsi J, Baden DG. Brevenal is a natural inhibitor of brevetoxins action in sodium channel receptor binding assays. Cellular and Molecular Neurobiology. 2004b;24:553–563. doi: 10.1023/B:CEMN.0000023629.81595.09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Bourdelais AJ, Jacocks HM, Wright JLC, Bigwarfe PM, Baden DG. A new polyether ladder compound produced by the dinoflagellate Karenia brevis. J Nat Prod. 2005;68(1):2–6. doi: 10.1021/np049797o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Brand LE, Compton A. Long-term increase in Karenia brevis abundance along the southwest Florida coast. Harmful Algae. 2007;6:232–252. doi: 10.1016/j.hal.2006.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Campbell SK, McConnell EP, Bourdelais A, Tomas C, Baden DG. The production of brevetoxin and brevetoxin-like compounds during the growth phases of Karenia brevis. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 148–149. [Google Scholar]
  33. Carvalho GA, Minnett PJ, Fleming LE, Banzon VF, Baringer W. Satellite remote sensing of harmful algal blooms: A new multi-algorithm method for detecting the Florida Red Tide (Karenia brevis) Harmful Algae. 2010;9:440–448. doi: 10.1016/j.hal.2010.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Centers for Disease Control and Prevention (CDC) Illness associated with red tide--Nassau County, Florida, 2007. MMWR - Morbidity & Mortality Weekly Report. 2008;57(26):717–720. [PubMed] [Google Scholar]
  35. Cheng YS, Villareal TA, Zhou Y, Gao J, Pierce RH, Naar J, Baden DG. Characterization of Red tide aerosol on the Texas coast. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2005. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 499–501. [Google Scholar]
  36. Cheng YS, Zhou Y, Irvin CM, Pierce RH, Naar J, Backer LC, Fleming LE, Kirkpatrick B, Baden DG. Characterization of Marine Aerosol for Assessment of Human Exposure to Brevetoxins. Environ Health Perspect. 2005a;113(5):638–643. doi: 10.1289/ehp.7496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Cheng YS, McDonald JD, Kracko D, Irvin CM, Zhou Y, Pierce RH, Henry MS, Bourdelais A, Naar J, Baden DG. Concentration and particle size of airborne toxic algae (brevetoxin) derived from ocean red tide events. Environ Sci & Technol. 2005b;39(10):3443–3449. doi: 10.1021/es048680j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cheng YS, Zhou Y, Irvin CM, Kirkpatrick B, Backer LC. Characterization of Aerosols Containing Microcystin. Marine Drugs. 2007;5:136–150. doi: 10.3390/md504136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Clarke TC, Sabater JR, Bourdelais AJ, Baden DG, Abraham WM. Epithelial and Voltage Sensitive Sodium Channel (VSSC) Blockers Modulate Elastase-Induced Slowing of Tracheal Mucus Velocity (TMV) in Sheep. Am. J. Respir. Crit. Care Med. 2008;177:A457. [Google Scholar]
  40. Crimmins MT, Zuccarello JL, Ellis JM, McDougall PJ, Haile PA, Parrish JD, Emmitte KA. Total synthesis of brevetoxin A. Organic Letters. 2009;11(2):489–492. doi: 10.1021/ol802710u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Dechraoui MY, Tiedeken JA, Persad R, Wang Z, Granade HR, Dickey RW, Ramsdell JS. Use of two detection methods to discriminate ciguatoxins from brevetoxins: application to great barracuda from Florida Keys. Toxicon. 2005;46(3):261–270. doi: 10.1016/j.toxicon.2005.04.006. [DOI] [PubMed] [Google Scholar]
  42. Dickey RW, Plakas SM, Jester ELE, ElSiad KR, Johannessen JN, Flewelling LJ, Scott P, Hammond DG, VanDolah FM, Leighfield TA, Bottein Y, Ramsdell JS, Busman M, Moeller PD, Pierce RH, Henry MS, Poli MA, Walker CS, Kurtz J, Naar J, Baden DG, Musser SM, Truman P, Quilliam MA, Stirling D, Hawryluk TP, Wekell MM, Hungerford JM, Yoshimoto K. Multi-laboratory study of five methods for the determination of brevetoxins in shellfish tissue extracts. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 300–302. [PMC free article] [PubMed] [Google Scholar]
  43. Fleming LE, Bean JA, Kirkpatrick B, Chung YS, Pierce R, Naar J, Nierenberg K, Backer LC, Wanner A, Reich A, Zhou Y, Watkins S, Henry M, Zaias J, Abraham WM, Benson J, Cassedy A, Hollenbeck J, Kirkpatrick G, Clarke T, Baden DG. Exposure and Effect Assessment of Aerosolized Red Tide Toxins (Brevetoxins) and Asthma Env Health Persp. 2009;117:1095–1100. doi: 10.1289/ehp.0900673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Fleming L, Kirkpatrick B, Backer LC, Bean JA, Wanner A, Reich A, Zaias J, Cheng YS, Pierce R, Naar J, Abraham W, Baden D. Aerosolized Red Tide Toxins (Brevetoxins) and Asthma. CHEST. 2007a;131(1):187–194. doi: 10.1378/chest.06-1830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Fleming LE, Backer L, Rowan A. The Epidemiology of Human Illnesses Associated with Harmful Algal Blooms. In: Baden D, Adams D, editors. Neurotoxicology Handbook. Volume 1. Totowa, NJ: Humana Press Inc; 2002. pp. 363–381. [Google Scholar]
  46. Fleming LE, Backer LC, Baden DG. Overview of Aerosolized Florida Red Tide Toxins: Exposures and Effects. Environ Health Perspect. 2005a;113(5):618–620. doi: 10.1289/ehp.7501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fleming LE, Bean JA, Katz D, Hammond R. Hui, Kits, Stanfield. Seafood and Environmental Toxins. Marcel Dekker; 2001. The Epidemiology of Seafood Poisoning; pp. 287–310. [Google Scholar]
  48. Fleming LE, Jerez E, Stephan WB, Cassedy A, Bean JA, Reich A, Kirkpatrick B, Backer L, Nierenberg K, Watkins S, Hollenbeck J, Weisman R. Evaluation of Harmful Algal Bloom Outreach Activities Marine Drugs. (Special Issue on Marine Toxins) 2007b;5:208–219. doi: 10.3390/md504208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Fleming LE, Kirkpatrick B, Backer LC, Bean JA, Wanner A, Dalpra D, Tamer R, Zaias J, Cheng YS, Pierce R, Naar J, Abraham W, Clark R, Zhou Y, Henry MS, Johnson D, Van De Bogart G, Bossart GD, Harrington M, Baden DG. Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ Health Perspect. 2005b;113(5):650–657. doi: 10.1289/ehp.7500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Fleming LE, Backer LC, Kirkpatrick B, Clark R, Dalpra D, Johnson DR, Bean JA, Cheng YS, Benson J, Squicciarrini D, Abraham WM, Pierce R, Zaias J, Naar J, Weisman R, Bossart G, Campbell S, Wanner A, Harrington M, Ban de Bogart G, Baden DG. In: An Epidemiologic Approach to the Study of Aerosolized Florida Red Tides. Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 508–510. [PMC free article] [PubMed] [Google Scholar]
  51. Flewelling LJ, Naar JP, Abbott JP, Baden DG, Barros NB, Bossart GD, Bottein M-YD, Hammond DG, Haubold EM, Heil CA, Henry MS, Jacocks HM, Leighfield TA, Pierce RH, Pitchford TD, Rommel SA, Scott PS, Steidinger KA, Truby EW, Van Dolah FM, Landsberg JH. Brevetoxicosis: Red tides and marine mammal mortalities. Nature (London, United Kingdom) . 2005;435(7043):755–756. doi: 10.1038/nature435755a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Fuwa H, Makoto E, Bourdelais J, Baden D, Sasaki M. Total Synthesis, structure revision and absolute configuration of (−)-brevenal. J Am Chem Soc. 2006;128(51):16989–16999. doi: 10.1021/ja066772y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Han TK, Derby M, Martin DF, Wright SD, Dao ML. Effects of brevetoxins on murine myeloma SP2/O cells: aberrant cellular division. Int J Toxicol. 2003;22:73–80. doi: 10.1080/10915810305095. [DOI] [PubMed] [Google Scholar]
  54. Hardman RC, Cooper WJ, Baden DG, Bourdelais AJ, Gardinali P. Brevetoxin degradation and by-product formation via natural sunlight. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; In Harmful Algae 2002. pp. 153–154. [Google Scholar]
  55. Haywood AJ, Steidinger KA, Truby EW, Bergquist PR, Bergquist PL, Adamson J, Mackenzie L. Comparative morphology and molecular phylogenetic analysis of 3 new species of the Genus Karenia (Dinophyceae) from New Zealand. Journal of Phycology. 2004;40(1):165–179. [Google Scholar]
  56. Hernandez-Becerril DU, Alonso-Rodriguez R, Alvarez-Gongora C, Baron-Campis SA, Ceballos-Corona G, Herrera-Silveira J, Meave Del Castillo ME, Juarez-Ruiz N, Merino-Virgilio F, Morales-Blake A, Ochoa JL, Orellana-Cepeda E, Ramirez-Camarena C, Rodriguez-Salvador R. Toxic and harmful marine phytoplankton and microalgae (HABs) in Mexican Coasts. Journal of Environmental Science & Health Part A-Toxic/Hazardous Substances & Environmental Engineering. 2007;42(10):1349–1363. doi: 10.1080/10934520701480219. [DOI] [PubMed] [Google Scholar]
  57. Hilderbrand SC, Murrell RN, Gibson JE, Brown JM. Marine brevetoxin induced IgE-independent mast cell activation. Arch Toxicol. 2010 June 13; doi: 10.1007/s00204-010-0564-2. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  58. Hoagland P, Anderson DM, Kaoru Y, White AW. The Economic Effects of Harmful Algal Blooms in the United States: Estimates, Assessment Issues, and Information Needs. Estuaries. 2002;25(4b):819–837. [Google Scholar]
  59. Hoagland P, Jin D, Polansky L, Kirkpatrick B, Kirkpatrick G, Fleming L, Reich A, Watkins S, Ullmann S, Backer L. The Costs of Respiratory Illnesses Arising from Florida Gulf Coast Karenia brevis. Blooms, Environmental Health Perspectives. 2009;117:1239–1243. doi: 10.1289/ehp.0900645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Katunuma N, Matsunaga Y, Himeno K, Hayashi Y. Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors. Bio Chem. 2003;384:883–890. doi: 10.1515/BC.2003.099. [DOI] [PubMed] [Google Scholar]
  61. Kirkpatrick B, Bean JA, Fleming LE, Backer LC, Akers R, Wanner A, Dalpra D, Nierenberg K, Reich A, Baden DG. Aerosolized Red Tide Toxins (Brevetoxins) and Asthma: A 10 day follow up after 1 hour acute beach exposure. In: Moestrup, et al., editors. Proceedings of the 12th International Conference on Harmful Algae; Copenhagen: International Society for Harmful Algae and Intergovernmental Oceanographic Commission of UNESCO; 2009b. pp. 297–299. [Google Scholar]
  62. Kirkpatrick B, Pierce R, Cheng YS, Henry MS, Blum P, Osborn S, Nierenberg K, Pederson BA, Fleming LE, Reich A, Naar J, Kirkpatrick G, Backer LC, Baden D. Inland Transport of Aerosolized Florida Red Tide Toxins Harmful Algae. 2010;9(2):123–242. doi: 10.1016/j.hal.2009.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Kirkpatrick B, Currier R, Nierenberg K, Reich A, Backer LC, Stumpf R, Fleming LE, Kirkpatrick G. Florida Red Tide and Human Health: A Pilot Beach Conditions Reporting System to Minimize Human Exposure. Science for the Total Environment. 2008;402:1–8. doi: 10.1016/j.scitotenv.2008.03.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kirkpatrick B, Bean JA, Fleming LE, Kirkpatrick G, Grief L, Nierenberg K, Reich A, Watkins S, Naar J. Gastrointestinal Emergency Room Admissions and Florida Red Tide Blooms Harmful Algae. 2009a;9:82–86. doi: 10.1016/j.hal.2009.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Kirkpatrick B, Fleming LE, Backer LLC, Bean JA, Tamer R, Kirkpatrick G, Kane T, Wanner A, Dalpra D, Kane T, Wanner A, Dalpra D, Reich A, Baden DG. Environmental exposures to Florida red tides: effects on emergency room respiratory diagnosis admissions. Harmful Algae. 2006;5:526–533. doi: 10.1016/j.hal.2005.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Kirkpatrick B, Fleming LE, Squicciarini D, Backer LC, Clark R, Abraham W, Benson J, Cheng YS, Johnson D, Pierce R, Zaias J, Bossart G, Baden DG. Literature Review of Florida Red Tide: Implications for Human Health Effects. Harmful Algae. 2004a;3(2):99–115. doi: 10.1016/j.hal.2003.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Kirkpatrick BA, Fleming LE, Henry M, Clark RD, Backer LC. The Use of Electronic Media to Educate and Communicate with the Public During a Harmful Algal Bloom. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004b. pp. 494–495. [Google Scholar]
  68. Kirkpatrick B, Colbert D, Dalpra D, Newton E, Gaspard J, Littlefield L, Manire C. Florida Red Tides, Manatee Brevetoxicosis, and Lung Models. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004a. pp. 491–493. [PMC free article] [PubMed] [Google Scholar]
  69. Kirkpatrick GJ, Schofield OE, Millie DF, Moline M. Optical discrimination of a phytoplankton species in natural mixed populations. Limnology and Oceanography. 2000;45:467–471. [Google Scholar]
  70. Kreuder C, Mazet J, Bossart GD, Carpenter T, Holyoak M, Elie M, Wright S. Clinicopathologic features of suspected brevetoxicosis in double-crested cormorants (Phalacrocorax auritus) along the Florida gulf coast. J Zoo Wildlife Med. 2002;33:8–15. doi: 10.1638/1042-7260(2002)033[0008:CFOSBI]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  71. Kuhar S, Nierenberg K, Kirkpatrick B, Tobin G. Public Perceptions of Florida Red Tide Risks. Risk Analysis. 2009;29:7. doi: 10.1111/j.1539-6924.2009.01228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Kuranaga T, Shirai T, Baden DG, Wright JL, Satake M, Tachibana K. Total synthesis and structural confirmation of brevisamide: a new marine cyclic ether alkaloid from the dinoflagellate Karenia brevis. Organic Letters. 2009;11:217–220. doi: 10.1021/ol802426v. [DOI] [PubMed] [Google Scholar]
  73. Lamberto JN, Bourdelais A, Jacocks HM, Tomas C, Baden DG. Effects of temperature on production of brevetoxin and brevetoxin-like compounds. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 155–156. [Google Scholar]
  74. Leighfield TA, Muha N, Ramsdell JS. Brevetoxin B is a clastogen in rats, but lacks mutagenic potential in the SP-98/100 Ames test. Toxicon. 2009;54(6):851–856. doi: 10.1016/j.toxicon.2009.06.018. [DOI] [PubMed] [Google Scholar]
  75. LePage KT, Baden DG, Murray TF. Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel. Brain Research. 2003;959:120–127. doi: 10.1016/s0006-8993(02)03737-x. [DOI] [PubMed] [Google Scholar]
  76. LePage KT, Rainer JD, Johnson HW, Baden DG, Murray TF. Gambierol acts as a functional antagonist of neurotoxin site 5 on voltage-gated sodium channels in cerebellar granule neurons. JPET. 2007;323:174–179. doi: 10.1124/jpet.107.124271. [DOI] [PubMed] [Google Scholar]
  77. Lidie KB, Ryan JC, Barbier M, Van Dolah FM. Gene expression in Florida red tide dinoflagellate Karenia brevis: analysis of an expressed sequence tag library and development of DNA microarray. Marine Biotechnology. 2005;7(5):481–493. doi: 10.1007/s10126-004-4110-6. [DOI] [PubMed] [Google Scholar]
  78. Lu Z, Tomchik SM. Effects of a red-tide toxin on fish hearing. Journal of Comparative Physiology A-Sensory Neural & Behavioral Physiology. 2002;188(10):807–813. doi: 10.1007/s00359-002-0369-8. [DOI] [PubMed] [Google Scholar]
  79. Mattei C, Wen PJ, Nguyen-Huu TD, Alvarez M, Benoit E, Bourdelais AJ, Lewis RJ, Baden DG, Molgo J, Meunier FA. Brevenal inhibits pacific ciguatoxin-1B–induced neurosecretion from bovine chromaffin cells. PLoS ONE. 2008;3:e3448. doi: 10.1371/journal.pone.0003448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Michelliza S, Jacocks H, Bourdelais A, Baden DG. Synthesis, binding assays, and toxicity of new derivatives of brevetoxin b. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental; 2004. [Google Scholar]
  81. Michelliza S, Abraham WM, Jacocks HM, Schuster T, Baden DG. Synthesis, Modeling, and Biological Evaluation of Analogs of the Semi-Semisynthetic Brevetoxin Antagonist b-Naphthoyl-Brevetoxin. ChemBioChem 2007. 2007;8:2233–2239. doi: 10.1002/cbic.200700317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Milian A, Nierenberg K, Fleming LE, Bean JA, Wanner A, Reich A, Backer LC, Jayroe D, Kirkpatrick B. Reported Respiratory Symptom Intensity in Asthmatics during Exposure to Aerosolized Florida Red Tide Toxins. J Asthma. 2007;44:583–587. doi: 10.1080/02770900701539251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Monroe EA, Van Dolah FM. The toxic dinoflagellate Karenia brevis encodes novel type I-like polyketide synthases containing discrete catalytic domains. Protist. 2008;159(3):471–482. doi: 10.1016/j.protis.2008.02.004. [DOI] [PubMed] [Google Scholar]
  84. Murrell RN, Gibson JE. Brevetoxins 2, 3, 6, and 9 show variability in potency and cause significant induction of DNA damage and apoptosis in Jurkat E6-1 cells. Arch Toxicol. 2009;83(11):1009–1019. doi: 10.1007/s00204-009-0443-x. [DOI] [PubMed] [Google Scholar]
  85. Murrell RN, Gibson JE. Brevetoxin 2 alters expression of apoptotic, DNA damage, and cytokine genes in Jurkat cells. Hum Exp Toxicol. 2010 May 24; doi: 10.1177/0960327110372644. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  86. Naar J, Weidner A, Baden DG. Competitive ELISA: an accurate, quick, and effective tool to monitor brevetoxins in environmental and biological samples. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 291–293. [PMC free article] [PubMed] [Google Scholar]
  87. Naar JP, Flewelling LJ, Lenzi A, Abbott JP, Granholm A, Jacocks HM, Gannon D, Henry M, Pierce R, Baden DG, Wolny J, Landsberg JH. Brevetoxins, like ciguatoxins, are potent ichthyotoxins that accumulate in fish. Toxicon. 2007;50:707–723. doi: 10.1016/j.toxicon.2007.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Naar J, Bourdelais AJ, Tomas CR, Whitney P, Lancaster J, Baden D. A competitive ELISA to detect brevetoxin from Gymnodinium breve in seawater, shellfish, and mammalian body fluid. Environ Health Perspect. 2002;110(2):179–185. doi: 10.1289/ehp.02110179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Nierenberg K, Reich A, Currier R, Kirkpatrick B, Backer L, Stumpf R, Fleming L, Kirkpatrick G. Beaches and HABs: Successful Expansion of the Florida Red Tide Reporting System for Protection of Public Health through Community Education and Outreach. Florida Journal of Environmental Health. 2009;203:18–24. [PMC free article] [PubMed] [Google Scholar]
  90. Nierenberg K, Kirner K, Hoagland P, Ullmann S, LeBlanc WG, Kirkpatrick G, Fleming LE, Kirkpatrick B. Changes in Work Habits of Lifeguards in Relation to Florida Red Tide. Harmful Algae. doi: 10.1016/j.hal.2010.02.005. doi:10.1016/j.hal.2010.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Nierenberg K, Byrne M, Fleming LE, Stephan W, Reich A, Backer LC, Tanga E, Dalpra D, Kirkpatrick B. Florida Red Tide Perception: Residents versus Tourists. Harmful Algae. doi: 10.1016/j.hal.2010.04.010. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Nozawa A, Tsuji K, Ishida H. Implication of brevetoxin B1 and PbTx-3 in neurotoxic shellfish poisoning in New Zealand by isolation and quantitative determination with liquid chromatography-tandem mass spectrometry. Toxicon. 2003;42(1):91–103. doi: 10.1016/s0041-0101(03)00123-5. [DOI] [PubMed] [Google Scholar]
  93. Okamoto K, Fleming LE. Wexler P. Encyclopedia of Toxicology. 2nd edition. Vol. 1. Oxford, England: Oxford University Press; 2005. Algae; pp. 68–76. [Google Scholar]
  94. Olascoaga MJ, Rypina II, Brown MG, Beron-Vera FJ, Kocak H, Brand LE, Halliwell GR, Shay LK. Persistent transport barrier on the West Florida Shelf. Geophysical Research Letters. 2006 doi: 10.1029/2006GL027800. doi:10.1029/2006gl027800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Perez Linares J, Ochoa JL, Gago Martinez A. Retention and tissue damage of PSP and NSP toxins in shrimp: Is cultured shrimp a potential vector of toxins to human population? Toxicon. 2009;53(2):185–195. doi: 10.1016/j.toxicon.2008.10.022. [DOI] [PubMed] [Google Scholar]
  96. Pierce RH, Henry MS, Bloom PC, Hamel SL, Kirkpatrick B, Cheng YS, Zhou Y, Irvin CM, Naar J, Weidner A, Fleming LE, Backer LC, Baden DG. Brevetoxin Composition in Water and Marine Aerosol along a Florida Beach: Assessing Potential Human Exposure to Marine Biotoxins. Harmful Algae. 2005;4/6:965–972. [Google Scholar]
  97. Pierce RH, Henry MS, Blum PC, Lyons J, Cheng YS, Yazzie D, Zhou Y. Brevetoxin concentrations in marine aerosol: Human exposure levels during a Karenia brevis harmful algal bloom. Bull. Environ.Contam. Toxicol. 2003;70:161–165. doi: 10.1007/s00128-002-0170-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Pierce RH, Henry MS. Harmful algal toxins of the Florida red tide (Karenia brevis): natural chemical stressors in South Florida coastal ecosystems. Ecotoxicology. 2008;17:623–631. doi: 10.1007/s10646-008-0241-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Plakas SM, Jester EL, El Said KR, Granade HR, Abraham A, Dickey RW, Scott PS, Flewelling LJ, Henry M, Blum P, Pierce R. Monitoring of brevetoxins in the Karenia brevis bloom-exposed Eastern oyster (Crassostrea virginica) Toxicon. 2008;52(1):32–38. doi: 10.1016/j.toxicon.2008.04.174. [DOI] [PubMed] [Google Scholar]
  100. Poli MA, Rivera VR, Neal DD, Baden DG, Messer SA, Plakas SM, Dickey RW, Said KE, Flewelling L, Green D, White J. An electrochemiluminesence-based competitive displacement immunosassay for the type-2 brevetoxins in oyster extracts. J AOAC Intl. 2007;90:173–178. [PMC free article] [PubMed] [Google Scholar]
  101. Potera C. Marine biology. Florida red tide brews up drug lead for cystic fibrosis. Science. 2007;316(5831):1561–1562. doi: 10.1126/science.316.5831.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Quirino W, Fleming LE, Weisman R, Backer L, Kirkpatrick B, Clark R, Dalpra D, Van de Bogart G, Gaines M. Follow up study of red tide associated respiratory illness. Fl J Env Health. 2004;186:18–22. [Google Scholar]
  103. Radwan FFY, Ramsdell JS. Characterization of in vitro oxidative and conjugative metabolic pathways for brevetoxin (PbTx-2) Toxicol Sci. 2006;89(1):57–65. doi: 10.1093/toxsci/kfj013. [DOI] [PubMed] [Google Scholar]
  104. Radwan FFY, Wang Z, Ramsdell JS. Rapid identification of a rapid detoxification mechanism for brevetoxin in rats. Toxicol Sci. 2005;85:839–846. doi: 10.1093/toxsci/kfi138. [DOI] [PubMed] [Google Scholar]
  105. Radwan FFY, Ramsdell JS. Brevetoxin forms covalent DNA adducts in rat lung following intratracheal exposure. Environ Health Perspect. 2008;116(7):930–936. doi: 10.1289/ehp.11068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Raloff J. Homing in on an alga's threat–and therapeutic promise. Sci News. 2005;168(4) [PMC free article] [PubMed] [Google Scholar]
  107. Red Tide Research Group. The Current of Red Tide Research. Env Health Perspect. 2002;110(3):132–133. doi: 10.1289/ehp.110-1240789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Rein KS, Snyder RV. The Biosynthesis of Polyketide Metabolites by Dinoflagellates. Adv Appl Micro. 2006;59:93–125. doi: 10.1016/S0065-2164(06)59004-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Sabater JR, Clarke TC, Abraham WM. Human Neutrophil Elastase Causes Prolonged Impairment of Whole Lung Mucociliary Clearance. Am. J. Respir. Crit. Care Med. 2009 Abstract. [Google Scholar]
  110. Sabater JR, Clarke TC, Bourdelais AJ, Baden DG, Abraham WM. Effects of Voltage Sensitive Sodium Channel (VSSC) Blockers on Normal and Impaired Whole Lung Mucociliary Clearance (MCC) in Sheep. Am. J. Respir. Crit. Care Med. 2008;177:A863. [Google Scholar]
  111. Satake M, Bourdelais A, VanWagoner R, Baden DG, Wright JL. Brevisamide: an unprecedented monocyclic ether alkaloid from the dinoflagellate Karenia brevis that provides a potential model for ladder-frame initiation. Org Lett. 2008;10:3465–3468. doi: 10.1021/ol801243n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Satake M, Campbell A, VanWagoner R, Bourdelais A, Jacocks H, Baden DG, Wright JL. Brevisin: an aberrant polycyclic ether structure from the dinoflagellate Karenia brevis and its implications for polyether assembly. J Org Chem. 2009;74:989–994. doi: 10.1021/jo802183n. [DOI] [PubMed] [Google Scholar]
  113. Sayer A, Hu Q, Bourdelais AJ, Baden DG, Gibson JE. The effect of brevenal on brevetoxin-induced DNA damage in human lymphocytes. Arch Toxicol. 2005;79:683–688. doi: 10.1007/s00204-005-0676-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Sayer AN, Hu Q, Bourdelais A, Baden DG, Gibson JE. The inhibition of CHO-K1-BH4 cell proliferation and induction of chromosomal aberrations by brevetoxins in vitro. Food & Chemical Toxicology. 2006;44:1082–1091. doi: 10.1016/j.fct.2006.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Steensma DP. Exacerbation of asthma by Florida "red tide" during an ocean sailing trip. Mayo Clinic Proceedings. 2007;82(9):1128–1130. doi: 10.4065/82.9.1128. [DOI] [PubMed] [Google Scholar]
  116. Steidinger KA. A re-evaluation of toxic dinoflagellate biology and ecology. Prog Phycolog Res. 1983;2:147–188. [Google Scholar]
  117. Stumpf R, Tomlinson M, Calkins J, Kirkpatrick B, Fisher K, Nierenberg K, Currier R, Wynne T. Skill Assessment for an Operational Algal Bloom Forecast System. Journal of Marine Systems. 2009;76:151–161. doi: 10.1016/j.jmarsys.2008.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Sudarsanam S, Virca GD, March CJ, Srinivasan S. An approach to computer-aided inhibitor design: application to cathepsin L. J Comput Aided Mol Des. 1992;6(3):223–233. doi: 10.1007/BF00123378. [DOI] [PubMed] [Google Scholar]
  119. Tibbetts BM, Baden DG, Benson JM. Uptake, tissue, distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation. J Toxicol Environ Health. 2006:1325–1335. doi: 10.1080/15287390500360091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Twiner MJ, Rehmann N, Hess P, Douchette G. Azaspiracid Shellfish Poisoning: A Review on the Chemistry, Ecology, and Toxicology with an Emphasis on Human Health Impacts. Mar Drugs. 2008;6(2):39–72. doi: 10.3390/md20080004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Twiner MJ, Bottein Dechraoui MY, Wang Z, Mikulski CM, Henry MS, Pierce RH, Doucette GJ. Extraction and analysis of lipophilic brevetoxins from the red tide dinoflagellate Karenia brevis. Analytical Biochemistry. 2007;369(1):128–135. doi: 10.1016/j.ab.2007.06.031. [DOI] [PubMed] [Google Scholar]
  122. Van Dolah FM, Douchette GJ, Gulland F, Rowles T, Bossartm G. Impacts of algal toxins on marine mammals. In: Vos JG, Bossart GD, Fournier M, O’Shea T, editors. Toxicology of Marine Mammals. London: Taylor & Francis; 2003. pp. 247–270. [Google Scholar]
  123. Walsh JJ, Joliff JK, Darrow BP, Lenes JM, Milroy SP, Dieterie DA, Chen FR, Vargo GA, Weisburg HR, Fanning K/A, Muller-Karger FE, Whitledge T/E, Stockwell D/A, Tomas CR, Villareal TA, Jochens AE. Red tides in the Gulf of Mexico: where, when and why? Journal of Geophysical Research C11003. 2006:1–46. doi: 10.1029/2004JC002813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Walsh CJ, Leggett SR, Henry MS, Blum PC, Osborn S, Pierce RH. Cellular metabolism of brevetoxin (PbTx-2) by a monocyte cell line (U-937) Toxicon. 2009;53:135–145. doi: 10.1016/j.toxicon.2008.10.024. [DOI] [PubMed] [Google Scholar]
  125. Walsh CJ, Luer CA, Noyes DR. Effects of environmental stressors on lymphocyte proliferation in the Florida manatee, Trichechus manatus latirostris. Vet Immunol Immunopathol. 2005;103(3–4):255–264. doi: 10.1016/j.vetimm.2004.09.026. [DOI] [PubMed] [Google Scholar]
  126. Walsh CJ, Leggett SR, Strohbehn K, Pierce RH, Sleasman JW. Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat) Mar Drugs. 2008;6:291–307. doi: 10.3390/md20080014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Walsh CJ, Leggett SR, Carter BJ, Colle C. Effects of brevetoxin exposure on the immune system of loggerhead sea turtles. Aquatic toxicology. 2010;97:293–303. doi: 10.1016/j.aquatox.2009.12.014. [DOI] [PubMed] [Google Scholar]
  128. Watkins S, Reich A, Fleming L, Hammond R. Neurotoxic Shellfish Poisoning. Marine Drugs. 2008;6:431–455. doi: 10.3390/md20080021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Weidner AL, Naar J, Steidinger KA, Pierce R, Henry M, Flewelling L, Baden DG. Variability of brevetoxin accumulation levels within individual oysters during Karenia brevis blooms. In: Steidinger KA, Landsberg JH, Tomas CR, Vargo GA, editors. In Harmful Algae 2002. St. Petersburg FL: Florida Fish and Wildlife Conservation Commission, Florida Institute of Oceanography, Intergovernmental Oceanographic Commission of UNESCO; 2004. pp. 485–487. [Google Scholar]
  130. Woofter RT, Ramsdell JS. Distribution of brevetoxin to lipoproteins in human plasma. Toxicon. 2007;49(7):1010–1018. doi: 10.1016/j.toxicon.2007.01.011. [DOI] [PubMed] [Google Scholar]
  131. Woofter R, Dechraoui MY, Garthwaite I, Towers NR, Gordeon CJ, Cordova J, Ramsdell JS. Measurement of brevetoxin levels by radioimmunoassay of blood collection cards after acute, long-term, and low-dose exposure to Karenia brevis. Environ Health Perspect. 2003;111(13):1595–1600. doi: 10.1289/ehp.6166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Woofter R, Brendtro K, Ramsdell JS. Uptake and elimination of brevetoxin in blood of striped mullet (Mugil cephalus) after aqueous exposure to Karenia brevis. Environ Health Perspect. 2005a;113(1):11–16. doi: 10.1289/ehp.7274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Woofter RT, Spiess PC, Ramsdell JS. Distribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins. Environ Health Perspect. 2005b;113(11):1491–1496. doi: 10.1289/ehp.8010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Wynne TT, Stumpf RP, Tomlinson MC, Ransibrahmanakul V, Villareal TA. Detecting Karenia brevis blooms and algal resuspension in the western Gulf of Mexico with satellite ocean color imagery. Harmful Algae. 2005;4(6):992–1003. [Google Scholar]
  135. Zaias J, Backer LC, Fleming LE. Harmful Algal Blooms (HABs) In: Rabinowitz P, Conti L, editors. Human-Animal Medicine: A clinical guide to toxins, zoonoses, and other shared health risks. New York: Elsevier Science Publishers; 2010. pp. 91–104. [Google Scholar]
  136. Zaias J, Botvinnikova Y, Fleming LE, Bossart GD, Baden DG, Abraham WM. Aerosolized Polyether Brevetoxin (PbTx) Causes Airway Hyperresponsiveness (AHR) and Airway Inflammation in Both Normal and Allergic Sheep. in press. [Google Scholar]

RESOURCES